PROTEOMICS SHARED RESOURCE
蛋白质组学共享资源
基本信息
- 批准号:8340104
- 负责人:
- 金额:$ 6.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-20 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylationApplications GrantsBindingBiologicalCancer Center Support GrantCancer EtiologyCancer PatientCellsCerebrospinal FluidComplexDataDiseaseDissociationEarly DiagnosisElectron TransportFundingHealth SciencesIndividualInformaticsInstitutesInstructionLabelLiquid substanceMalignant NeoplasmsMass Spectrum AnalysisModificationOregonPatientsPhosphorylationPost-Translational Protein ProcessingProductivityProteinsProteomicsProteomics Shared ResourceRelative (related person)ResearchResearch PersonnelSalivaSamplingSerumSpeedStable Isotope LabelingSubcellular FractionsTechniquesTechnologyTissuesUniversitiesUrineWagesWorkWritinganticancer researcheffective therapyimprovedmass spectrometermembertool
项目摘要
The Proteomics Shared Resource provides modern tools of mass spectrometry to Knight Cancer Institute members so that they may determine the identity, abundance, and modifications occurring in proteins, the building blocks of the cell. These analyses are crucial to understanding the cause of cancer and devising improved treatments for the disease, since changes in proteins occur in all forms of cancer. Support will be
used to partially fund salaries of five staff and four state-of-the-art mass spectrometers to assist Knight investigators studying cancer-causing changes in proteins, including phosphorylation, acetylation, changes in abundance and altered binding to other proteins. A wide array of informatics tools and expertise will also be provided to Knight members to increase their research productivity. The results from the Proteomics
Shared Resource will be used to better treat cancer patients by providing earlier diagnosis of the disease and discovering more effective treatments that are personalized for individual patients.
蛋白质组学共享的资源为骑士癌症研究所成员提供了现代的质谱工具,以便他们可以确定蛋白质中发生的身份,丰度和修饰。这些分析对于理解癌症的原因并设计了改善该疾病的治疗方法至关重要,因为蛋白质的变化发生在各种形式的癌症中。支持将是
用于部分资助五名员工和四个最先进的质谱仪的薪水,以帮助研究蛋白质引起癌症变化的骑士研究人员,包括磷酸化,乙酰化,丰度变化和与其他蛋白质的结合改变。还将向骑士成员提供各种信息学工具和专业知识,以提高其研究生产力。蛋白质组学的结果
共享资源将通过提供对疾病的较早诊断并发现针对个别患者个性化的更有效治疗方法来更好地治疗癌症患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRIAN J DRUKER其他文献
BRIAN J DRUKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRIAN J DRUKER', 18)}}的其他基金
Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia
急性髓系白血病早期和晚期耐药机制的蛋白质组学特征
- 批准号:
10460000 - 财政年份:2022
- 资助金额:
$ 6.13万 - 项目类别:
Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia
急性髓系白血病早期和晚期耐药机制的蛋白质组学特征
- 批准号:
10646375 - 财政年份:2022
- 资助金额:
$ 6.13万 - 项目类别:
Knight Scholars Program - Building STEM Interest and Capacity for Cancer Research Careers among Underrepresented and Rural High School Students
奈特学者计划 - 培养代表性不足和农村高中生癌症研究职业的 STEM 兴趣和能力
- 批准号:
9788295 - 财政年份:2018
- 资助金额:
$ 6.13万 - 项目类别:
Knight Scholars Program - Building STEM Interest and Capacity for Cancer Research Careers among Underrepresented and Rural High School Students
奈特学者计划 - 培养代表性不足和农村高中生癌症研究职业的 STEM 兴趣和能力
- 批准号:
10003014 - 财政年份:2018
- 资助金额:
$ 6.13万 - 项目类别:
Knight Scholars Program - Building STEM Interest and Capacity for Cancer Research Careers among Underrepresented and Rural High School Students
奈特学者计划 - 培养代表性不足和农村高中生癌症研究职业的 STEM 兴趣和能力
- 批准号:
10605266 - 财政年份:2018
- 资助金额:
$ 6.13万 - 项目类别:
Knight Scholars Program - Building STEM Interest and Capacity for Cancer Research Careers among Underrepresented and Rural High School Students
奈特学者计划 - 培养代表性不足和农村高中生癌症研究职业的 STEM 兴趣和能力
- 批准号:
10381451 - 财政年份:2018
- 资助金额:
$ 6.13万 - 项目类别:
Dissecting Single-cell Response or resistance to novel combination therapy in AML using mass cytometry
使用质谱流式细胞仪剖析单细胞对 AML 新型联合疗法的反应或耐药
- 批准号:
10411840 - 财政年份:2017
- 资助金额:
$ 6.13万 - 项目类别:
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
血液系统恶性肿瘤中通路靶向和免疫调节治疗组合的功能基因组发现
- 批准号:
10238859 - 财政年份:2017
- 资助金额:
$ 6.13万 - 项目类别:
Translating Improved Pairing and Timing of Drug Combination Strategies
转化药物组合策略的改进配对和时机
- 批准号:
10684113 - 财政年份:2017
- 资助金额:
$ 6.13万 - 项目类别:
Architecture and Trajectory of Acquired Resistance to Therapy in AML
AML 获得性治疗耐药的结构和轨迹
- 批准号:
10684101 - 财政年份:2017
- 资助金额:
$ 6.13万 - 项目类别:
相似海外基金
Dissecting innate immune signaling in pre-leukemia evolution
剖析白血病前期进化中的先天免疫信号
- 批准号:
10584536 - 财政年份:2022
- 资助金额:
$ 6.13万 - 项目类别:
Dissecting innate immune signaling in pre-leukemia evolution
剖析白血病前期进化中的先天免疫信号
- 批准号:
10462192 - 财政年份:2022
- 资助金额:
$ 6.13万 - 项目类别:
Novel mitochondrial protective properties of annexin A1
膜联蛋白 A1 的新型线粒体保护特性
- 批准号:
10343330 - 财政年份:2021
- 资助金额:
$ 6.13万 - 项目类别:
Novel mitochondrial protective properties of annexin A1
膜联蛋白 A1 的新型线粒体保护特性
- 批准号:
10661073 - 财政年份:2021
- 资助金额:
$ 6.13万 - 项目类别:
Investigations of targets, mechanisms, and optimal delivery of therapeutic ketosis for functional longevity and treatment of Alzheimer's disease
研究酮症治疗的靶标、机制和最佳给药方式,以实现功能性长寿和阿尔茨海默氏病的治疗
- 批准号:
10203670 - 财政年份:2019
- 资助金额:
$ 6.13万 - 项目类别: